|
References
Adachi, Y., Taketani, S., Oyaizu, H., Ikebukuro, K., Tokunaga, R. and Ikehara, S. (1999) Apoptosis of colorectal adenocarcinoma induced by 5-FU and/or IFN-gamma through caspase 3 and caspase 8. Int J Oncol, 15, 1191-1196.
Adams, J.M. and Cory, S. (2002) Apoptosomes: engines for caspase activation. Curr Opin Cell Biol, 14, 715-720.
Agarwal, B., Bhendwal, S., Halmos, B., Moss, S.F., Ramey, W.G. and Holt, P.R. (1999) Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin Cancer Res, 5, 2223-2229.
Albright, C.F., Giddings, B.W., Liu, J., Vito, M. and Weinberg, R.A. (1993) Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. Embo J, 12, 339-347.
Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. and Saltiel, A.R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem, 270, 27489-27494.
Alnemri, E.S. (1997) Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J Cell Biochem, 64, 33-42.
Andresson, T. and Ruderman, J.V. (1998) The kinase Eg2 is a component of the Xenopus oocyte progesterone-activated signaling pathway. EMBO Journal, 17, 5627-5637.
Arango, D., Corner, G.A., Wadler, S., Catalano, P.J. and Augenlicht, L.H. (2001) c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo. Cancer Res, 61, 4910-4915.
Augenlicht, L.H., Wadler, S. and Arango, D. (2001) Clinical response to fluorouracil and p53. N Engl J Med, 345, 1065-1066.
Barbacid, M. (1987) Ras genes. Annu Rev Biochem, 56, 779-827.
Bar-Shira, A., Pinthus, J.H., Rozovsky, U., Goldstein, M., Sellers, W.R., Yaron, Y., Eshhar, Z. and Orr-Urtreger, A. (2002) Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res, 62, 6803-6807.
Berdnik, D. and Knoblich, J.A. (2002) Drosophila Aurora-A Is Required for Centrosome Maturation and Actin-Dependent Asymmetric Protein Localization during Mitosis. Curr Biol, 12, 640-647.
Bernal, S.D., Shapiro, H.M. and Chen, L.B. (1982) Monitoring the effect of anti-cancer drugs on L1210 cells by a mitochondrial probe, rhodamine-123. Int J Cancer, 30, 219-224.
Bischoff, J.R., Anderson, L., Zhu, Y., Mossie, K., Ng, L., Souza, B., Schryver, B., Flanagan, P., Clairvoyant, F., Ginther, C., Chan, C.S., Novotny, M., Slamon, D.J. and Plowman, G.D. (1998) A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J, 17, 3052-3065.
Bischoff, J.R. and Plowman, G.D. (1999) The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends in Cell Biology, 9, 454-459.
Bos, J.L. (1989) Ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689.
Brunet, S., Sardon, T., Zimmerman, T., Wittmann, T., Pepperkok, R., Karsenti, E. and Vernos, I. (2004) Characterization of the TPX2 domains involved in microtubule nucleation and spindle assembly in Xenopus egg extracts. Mol Biol Cell, 15, 5318-5328.
Budihardjo, I., Oliver, H., Lutter, M., Luo, X. and Wang, X. (1999) Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol, 15, 269-290.
Campbell, S.L., Khosravi-Far, R., Rossman, K.L., Clark, G.J. and Der, C.J. (1998) Increasing complexity of Ras signaling. Oncogene, 17, 1395-1413.
Cantor, S.B., Urano, T. and Feig, L.A. (1995) Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol Cell Biol, 15, 4578-4584.
Castro, A., Arlot-Bonnemains, Y., Vigneron, S., Labbe, J.C., Prigent, C. and Lorca, T. (2002) APC/Fizzy-Related targets Aurora-A kinase for proteolysis. EMBO Rep, 3, 457-462.
Chan, C.S. and Botstein, D. (1993) Isolation and characterization of chromosome-gain and increase-in-ploidy mutants in yeast. Genetics, 135, 677-691.
Chan, T.O., Rittenhouse, S.E. and Tsichlis, P.N. (1999) AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem, 68, 965-1014.
Chang, E.H., Gonda, M.A., Ellis, R.W., Scolnick, E.M. and Lowy, D.R. (1982) Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc Natl Acad Sci U S A, 79, 4848-4852.
Chang, F., Steelman, L.S., Shelton, J.G., Lee, J.T., Navolanic, P.M., Blalock, W.L., Franklin, R. and McCubrey, J.A. (2003) Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). Int J Oncol, 22, 469-480.
Chang, M.Y., Jan, M.S., Won, S.J. and Liu, H.S. (1998) Ha-rasVal12 oncogene increases susceptibility of NIH/3T3 cells to lovastatin. Biochem Biophys Res Commun, 248, 62-68.
Chang, M.Y., Won, S.J., Yang, B.C., Jan, M.S. and Liu, H.S. (1999) Selective activation of Ha-ras(val12) oncogene increases susceptibilityof NIH/3T3 cells to TNF-alpha. Exp Cell Res, 248, 589-598.
Chen, C.J., Chuang, Y.C., Lin, T.M. and Wu, H.Y. (1985) Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res, 45, 5895-5899.
Chen, C.J., Chuang, Y.C., You, S.L., Lin, T.M. and Wu, H.Y. (1986) A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer, 53, 399-405.
Chen, C.J. and Wang, C.J. (1990) Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res, 50, 5470-5474.
Chen, G., Oh, S., Monia, B.P. and Stacey, D.W. (1996) Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts. J Biol Chem, 271, 28259-28265.
Chen, K.P. and Wu, H.Y. (1969) Epidemiologic studies on blackfoot disease in Taiwan, China. 6. Effect of the piped water supply on occurrence and disease progress of blackfoot disease. Taiwan Yi Xue Hui Za Zhi, 68, 291-295.
Chen, S.L., Yeh, S.J., Yang, M.H. and Lin, T.H. (1995) Trace element concentration and arsenic speciation in the well water of a Taiwan area with endemic blackfoot disease. Biol Trace Elem Res, 48, 263-274.
Ch'i, I.C. and Blackwell, R.Q. (1968) A controlled retrospective study of Blackfoot disease, an endemic peripheral gangrene disease in Taiwan. Am J Epidemiol, 88, 7-24.
Chiang, P.H., Huang, M.S., Tsai, C.J., Tsai, E.M., Huang, C.H. and Chiang, C.P. (1993) Transitional cell carcinoma of the renal pelvis and ureter in Taiwan. DNA analysis by flow cytometry. Cancer, 71, 3988-3992.
Chiou, H.Y., Hsueh, Y.M., Liaw, K.F., Horng, S.F., Chiang, M.H., Pu, Y.S., Lin, J.S., Huang, C.H. and Chen, C.J. (1995) Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res, 55, 1296-1300.
Choy, E., Chiu, V.K., Silletti, J., Feoktistov, M., Morimoto, T., Michaelson, D., Ivanov, I.E. and Philips, M.R. (1999) Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell, 98, 69-80.
Clyde-Smith, J., Silins, G., Gartside, M., Grimmond, S., Etheridge, M., Apolloni, A., Hayward, N. and Hancock, J.F. (2000) Characterization of RasGRP2, a plasma membrane-targeted, dual specificity Ras/Rap exchange factor. J Biol Chem, 275, 32260-32267.
Cohen, G.M. (1997) Caspases: the executioners of apoptosis. Biochem J, 326, 1-16.
Cory, S. and Adams, J.M. (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer, 2, 647-656.
Cox, A.D. and Der, C.J. (2003) The dark side of Ras: regulation of apoptosis. Oncogene, 22, 8999-9006.
Crosio, C., Fimia, G.M., Loury, R., Kimura, M., Okano, Y., Zhou, H., Sen, S., Allis, C.D. and Sassone-Corsi, P. (2002) Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol Cell Biol, 22, 874-885.
Das, B., Shu, X., Day, G.J., Han, J., Krishna, U.M., Falck, J.R. and Broek, D. (2000) Control of intramolecular interactions between the pleckstrin homology and Dbl homology domains of Vav and Sos1 regulates Rac binding. J Biol Chem, 275, 15074-15081.
Davis, M.A., Chang, S.H. and Trump, B.F. (1996) Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis. Toxicol Appl Pharmacol, 141, 93-101.
Davis, R.J. (1995) Transcriptional regulation by MAP kinases. Mol Reprod Dev, 42, 459-467.
de Rooij, J. and Bos, J.L. (1997) Oncogene, 14, 623-625.
DeFeo, D., Gonda, M.A., Young, H.A., Chang, E.H., Lowy, D.R., Scolnick, E.M. and Ellis, R.W. (1981) Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci U S A, 78, 3328-3332.
del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R. and Nunez, G. (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science, 278, 687-689.
DeSalle, L.M. and Pagano, M. (2001) Regulation of the G1 to S transition by the ubiquitin pathway. FEBS Lett, 490, 179-189.
Dhillon, A.S., Pollock, C., Steen, H., Shaw, P.E., Mischak, H. and Kolch, W. (2002) Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol Cell Biol, 22, 3237-3246.
Dragovich, T., Rudin, C.M. and Thompson, C.B. (1998) Signal transduction pathways that regulate cell survival and cell death. Oncogene, 17, 3207-3213.
Du, J. and Hannon, G.J. (2002) The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1. Nucleic Acids Res, 30, 5465-5475.
Du, J. and Hannon, G.J. (2004) Suppression of p160ROCK bypasses cell cycle arrest after Aurora-A/STK15 depletion. Proc Natl Acad Sci U S A, 101, 8975-8980. Epub 2004 Jun 8973.
Duan, H., Tsvetkov, L.M., Liu, Y., Song, Y., Swaroop, M., Wen, R., Kung, H.F., Zhang, H. and Sun, Y. (2001) Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: association with inhibition of p27 accumulation. Mol Carcinog, 30, 37-46.
Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J. and Saltiel, A.R. (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A, 92, 7686-7689.
Dumaz, N. and Marais, R. (2003) Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J Biol Chem, 278, 29819-29823.
Dutertre, S., Descamps, S. and Prigent, C. (2002) On the role of aurora-A in centrosome function. Oncogene, 21, 6175-6183.
Edinger, A.L. and Thompson, C.B. (2003) Defective autophagy leads to cancer. Cancer Cell, 4, 422-424.
Ehrhardt, A., Ehrhardt, G.R., Guo, X. and Schrader, J.W. (2002) Ras and relatives--job sharing and networking keep an old family together. Exp Hematol, 30, 1089-1106.
Esteban, L.M., Vicario-Abejon, C., Fernandez-Salguero, P., Fernandez-Medarde, A., Swaminathan, N., Yienger, K., Lopez, E., Malumbres, M., McKay, R., Ward, J.M., Pellicer, A. and Santos, E. (2001) Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol Cell Biol, 21, 1444-1452.
Favata, M.F., Horiuchi, K.Y., Manos, E.J., Daulerio, A.J., Stradley, D.A., Feeser, W.S., Van Dyk, D.E., Pitts, W.J., Earl, R.A., Hobbs, F., Copeland, R.A., Magolda, R.L., Scherle, P.A. and Trzaskos, J.M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem, 273, 18623-18632.
Feig, L.A. and Buchsbaum, R.J. (2002) Cell signaling: life or death decisions of ras proteins. Curr Biol, 12, R259-261.
Filmus, J., Robles, A.I., Shi, W., Wong, M.J., Colombo, L.L. and Conti, C.J. (1994) Induction of cyclin D1 overexpression by activated ras. Oncogene, 9, 3627-3633.
Francisco, L. and Chan, C.S. (1994) Regulation of yeast chromosome segregation by Ipl1 protein kinase and type 1 protein phosphatase. Cell Mol Biol Res, 40, 207-213.
Frank-Vaillant, M., Haccard, O., Thibier, C., Ozon, R., Arlot-Bonnemains, Y., Prigent, C. and Jessus, C. (2000) Progesterone regulates the accumulation and the activation of Eg2 kinase in Xenopus oocytes. J Cell Sci, 113, 1127-1138.
Garrington, T.P. and Johnson, G.L. (1999) Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol, 11, 211-218.
Geng, Y., Gheuens, E. and de Bruijn, E.A. (1991) Activation and cytotoxicity of 5'-deoxy-5-fluorouridine in c-H-ras transformed NIH 3T3 cells. Biochem Pharmacol, 41, 301-303.
Giet, R. and Glover, D.M. (2001) Drosophila aurora B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis. Journal of Cell Biology, 152, 669-682.
Giet, R., McLean, D., Descamps, S., Lee, M.J., Raff, J.W., Prigent, C. and Glover, D.M. (2002) Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules. J Cell Biol, 156, 437-451. Epub 2002 Feb 2004.
Giet, R. and Prigent, C. (1999) Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. Journal of Cell Science, 112, 3591-3601.
Gigoux, V., L'Hoste, S., Raynaud, F., Camonis, J. and Garbay, C. (2002) Identification of Aurora kinases as RasGAP Src homology 3 domain-binding proteins. J Biol Chem, 277, 23742-23746.
Gille, H. and Downward, J. (1999) Multiple ras effector pathways contribute to G(1) cell cycle progression. J Biol Chem, 274, 22033-22040.
Gille, H., Strahl, T. and Shaw, P.E. (1995) Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Current Biology, 5, 1191-1200.
Glover, D.M., Leibowitz, M.H., McLean, D.A. and Parry, H. (1995) Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell, 81, 95-105.
Goldstein, J.C., Waterhouse, N.J., Juin, P., Evan, G.I. and Green, D.R. (2000) The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol, 2, 156-162.
Gomez, J., Martinez, C., Fernandez, B., Garcia, A. and Rebollo, A. (1997) Ras activation leads to cell proliferation or apoptotic cell death upon interleukin-2 stimulation or lymphokine deprivation, respectively. Eur J Immunol, 27, 1610-1618.
Gomez, J., Martinez-A, C. and Rebollo, A. (1996) Ras-mediated cell proliferation and cell death: some clues from the interleukin-2 receptor system. Apoptosis, 1, 175-182.
Gopalan, G., Chan, C.S. and Donovan, P.J. (1997) A novel mammalian, mitotic spindle-associated kinase is related to yeast and fly chromosome segregation regulators. Journal of Cell Biology, 138, 643-656.
Gorski, S.M., Chittaranjan, S., Pleasance, E.D., Freeman, J.D., Anderson, C.L., Varhol, R.J., Coughlin, S.M., Zuyderduyn, S.D., Jones, S.J. and Marra, M.A. (2003) A SAGE approach to discovery of genes involved in autophagic cell death. Curr Biol, 13, 358-363.
Green, D.R. and Evan, G.I. (2002) A matter of life and death. Cancer Cell, 1, 19-30.
Hamilton, J.M., Sznol, M. and Friedman, M.A. (1990) 5-Fluorouracil plus levamisole: effective adjuvant treatment for colon cancer. Important Adv Oncol, 115-130.
Han, J., Luby-Phelps, K., Das, B., Shu, X., Xia, Y., Mosteller, R.D., Krishna, U.M., Falck, J.R., White, M.A. and Broek, D. (1998) Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science, 279, 558-560.
Hancock, J.F. (2003) Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol, 4, 373-384.
Hancock, J.F., Cadwallader, K., Paterson, H. and Marshall, C.J. (1991) A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. Embo J, 10, 4033-4039.
Hancock, J.F., Cadwaller, K., Paterson, H. and Marshall, C.J. (1992) A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. EMBO J. 10, 4033-4039. Trends Cell Biol, 2, 73.
Hancock, J.F., Paterson, H. and Marshall, C.J. (1990) A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell, 63, 133-139.
Hannak, E., Kirkham, M., Hyman, A.A. and Oegema, K. (2001) Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans. J Cell Biol, 155, 1109-1116.
Hartsough, M.T., Morrison, D.K., Salerno, M., Palmieri, D., Ouatas, T., Mair, M., Patrick, J. and Steeg, P.S. (2002) Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem, 277, 32389-32399.
Head, J.E. and Johnston, S.R. (2003) Protein farnesyltransferase inhibitors. Expert Opin Emerg Drugs, 8, 163-178.
Hekman, M., Hamm, H., Villar, A.V., Bader, B., Kuhlmann, J., Nickel, J. and Rapp, U.R. (2002) Associations of B- and C-Raf with cholesterol, phosphatidylserine, and lipid second messengers: preferential binding of Raf to artificial lipid rafts. J Biol Chem, 277, 24090-24102.
Hernandez-Munoz, I., Malumbres, M., Leonardi, P. and Pellicer, A. (2000) The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways. Oncogene, 19, 2745-2757.
Hirata, H., Takahashi, A., Kobayashi, S., Yonehara, S., Sawai, H., Okazaki, T., Yamamoto, K. and Sasada, M. (1998) Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med, 187, 587-600.
Hofer, F., Fields, S., Schneider, C. and Martin, G.S. (1994) Activated Ras interacts with the Ral guanine nucleotide stimulator. Proc Natl Acad Sci U S A, 91, 11089-11093.
Holmlund, J.T., Monia, B.P., Kwoh, T.J. and Dorr, F.A. (1999) Toward antisense oligonucleotide therapy for cancer: ISIS compounds in clinical development. Curr Opin Mol Ther, 1, 372-385.
Holt, K.H., Waters, S.B., Okada, S., Yamauchi, K., Decker, S.J., Saltiel, A.R., Motto, D.G., Koretzky, G.A. and Pessin, J.E. (1996) Epidermal growth factor receptor targeting prevents uncoupling of the Grb2-SOS complex. J Biol Chem, 271, 8300-8306.
Hsu, J.Y., Sun, Z.W., Li, X., Reuben, M., Tatchell, K., Bishop, D.K., Grushcow, J.M., Brame, C.J., Caldwell, J.A., Hunt, D.F., Lin, R., Smith, M.M. and Allis, C.D. (2000) Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell, 102, 279-291.
Ikebukuro, K., Adachi, Y., Toki, J., Taketani, S., Tokunaga, R., Hioki, K. and Ikehara, S. (2000) Morphological change, loss of deltapsi(m) and activation of caspases upon apoptosis of colorectal adenocarcinoma induced by 5-FU. Cancer Lett, 153, 101-108.
Inada, T., Ichikawa, A., Igarashi, S., Kubota, T. and Ogata, Y. (1997a) Effect of preoperative 5-fluorouracil on apoptosis of advanced gastric cancer. J Surg Oncol, 65, 106-110.
Inada, T., Ichikawa, A., Kubota, T., Ogata, Y., Moossa, A.R. and Hoffman, R.M. (1997b) 5-FU-induced apoptosis correlates with efficacy against human gastric and colon cancer xenografts in nude mice. Anticancer Res, 17, 1965-1971.
Inada, T., Ichikawa, A., Igarashi, S., Kubota, T., and Ogata, T. (1997b) Effect of preoprative 5-fluorouracil on apoptosis of advanced gastric cancer. J. Surgical Oncology, 65, 106-110.
Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J., Der, C.J., Fearon, E.R., Sundaresan, M., Finkel, T. and Goldschmidt-Clermont, P.J. (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science, 275, 1649-1652.
Jacobsen, K., Groth, A. and Willumsen, B.M. (2002) Ras-inducible immortalized fibroblasts: focus formation without cell cycle deregulation. Oncogene, 21, 3058-3067.
Janknecht, R., Ernst, W.H., Pingoud, V. and Nordheim, A. (1993) Activation of ternary complex factor Elk-1 by MAP kinases. EMBO Journal, 12, 5097-5104.
Jeng, Y.M., Peng, S.Y., Lin, C.Y. and Hsu, H.C. (2004) Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res, 10, 2065-2071.
Jones, M.K. and Jackson, J.H. (1998) Ras-GRF activates Ha-Ras, but not N-Ras or K-Ras 4B, protein in vivo. J Biol Chem, 273, 1782-1787.
Jullien-Flores, V., Dorseuil, O., Romero, F., Letourneur, F., Saragosti, S., Berger, R., Tavitian, A., Gacon, G. and Camonis, J.H. (1995) Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem, 270, 22473-22477.
Kaiser, H.E. and Bodey, B. (2000) The role of apoptosis in normal ontogenesis and solid human neoplasms. In Vivo, 14, 789-803.
Karin, M. (1994) Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr Opin Cell Biol, 6, 415-424.
Katayama, H., Brinkley, W.R. and Sen, S. (2003) The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev, 22, 451-464.
Katz, M.E. and McCormick, F. (1997) Signal transduction from multiple Ras effectors. Current Opinion in Genetics & Development, 7, 75-79.
Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J. and Evan, G. (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature, 385, 544-548.
Kawata, S., Yamasaki, E., Nagase, T., Inui, Y., Ito, N., Matsuda, Y., Inada, M., Tamura, S., Noda, S., Imai, Y. and Matsuzawa, Y. (2001) Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial. Br J Cancer, 84, 886-891.
Kennedy, S.G., Wagner, A.J., Conzen, S.D., Jordan, J., Bellacosa, A., Tsichlis, P.N. and Hay, N. (1997) The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev, 11, 701-713.
Kerr, J.F., Wyllie, A.H. and Currie, A.R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 26, 239-257.
Kikuchi, A., Demo, S.D., Ye, Z.H., Chen, Y.W. and Williams, L.T. (1994) ralGDS family members interact with the effector loop of ras p21. Mol Cell Biol, 14, 7483-7491.
Kimura, M., Kotani, S., Hattori, T., Sumi, N., Yoshioka, T., Todokoro, K. and Okano, Y. (1997a) Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1. Journal of Biological Chemistry, 272, 13766-13771.
Kimura, M., Matsuda, Y., Eki, T., Yoshioka, T., Okumura, K., Hanaoka, F. and Okano, Y. (1997b) Assignment of STK6 to human chromosome 20q13.2-->q13.3 and a pseudogene STK6P to 1q41-->q42. Cytogenetics & Cell Genetics, 79, 201-203.
Koera, K., Nakamura, K., Nakao, K., Miyoshi, J., Toyoshima, K., Hatta, T., Otani, H., Aiba, A. and Katsuki, M. (1997) K-ras is essential for the development of the mouse embryo. Oncogene, 15, 1151-1159.
Koshiji, M., Adachi, Y., Taketani, S., Takeuchi, K., Hioki, K., and Ikehara,S. (1997) mechanisms underlying apoptosis induced by combination of 5-fluorouracil and interferon-gamma. Biochem. Biophy. Res.
commun., 240, 376-381.
Krebs, J., Armstrong,RC., Srinivasan, A., Aja, T/. Wong, AM., Aboy, A., Sayers, R., Pham, B., Vu, T., Hoang, K., Karanewsky, DS, Leist, C., Schmitz, A., Wu,JC., Tomaselli, KJ.. and Fritz, LC. (1999) Activation of membrane-associated procaspase-3 is regulated by Bcl-2. J. Cell. Biol., 144, 915-926.
Kuwana, T., Smith, J.J., Muzio, M., Dixit, V., Newmeyer, D.D. and Kornbluth, S. (1998) Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem, 273, 16589-16594.
Laufman, L.R., Krzeczowski, K.A., Roach, R. and Segal, M. (1987) Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon cancer. J Clin Oncol, 5, 1394-1400.
Lee, C.Y., Clough, E.A., Yellon, P., Teslovich, T.M., Stephan, D.A. and Baehrecke, E.H. (2003) Genome-wide analyses of steroid- and radiation-triggered programmed cell death in Drosophila. Curr Biol, 13, 350-357.
Lee, W., Schwab, M., Westway, D. and Varmus, H.E. (1985) Molecular & Cellular Biochemistry, 5, 3345-3356.
Lee, Y.L., Shih, M.C., Wu, W.J., Chou, Y.H. and Huang, C.H. (2002) Clinical and urographic presentation of transitional cell carcinoma of the ureter in a blackfoot disease endemic area in southern Taiwan. Kaohsiung J Med Sci, 18, 443-449.
Li, D., Zhu, J., Firozi, P.F., Abbruzzese, J.L., Evans, D.B., Cleary, K., Friess, H. and Sen, S. (2003) Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res, 9, 991-997.
Li, X., Hui, A.M., Shi, Y.Z., Sun, L., Takayama, T. and Makuuchi, M. (2002) Deregulation of G1/S transition is a common event in carcinoma of the ampulla of vater. Hepatogastroenterology, 49, 1239-1244.
Lima, W.F., Monia, B.P., Ecker, D.J. and Freier, S.M. (1992) Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry, 31, 12055-12061.
Liou, S.H., Lung, J.C., Chen, Y.H., Yang, T., Hsieh, L.L., Chen, C.J. and Wu, T.N. (1999) Increased chromosome-type chromosome aberration frequencies as biomarkers of cancer risk in a blackfoot endemic area. Cancer Res, 59, 1481-1484.
Littlepage, L.E. and Ruderman, J.V. (2002) Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit. Genes Dev, 16, 2274-2285.
Liu, H.S., Chen, C.Y., Lee, C.H. and Chou, Y.I. (1998) Selective activation of oncogenic Ha-ras induced apoptosis in NIH/3T3 cells. Br. J . Cancer, 77, 1777-1786.
Liu, H.S., Scrable, H., Villaret, D.B., Lieberman, M.A. and Stambrook, P.J. (1992) Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Cancer Res., 52, 983-989.
Liu, X., Kim, C.N., Yang, J., Jemmerson, R. and Wang, X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86, 147-157.
Lowy, D.R. and Willumsen, B.M. (1993) Function and regulation of ras. Annu Rev Biochem, 62, 851-891.
Lu, F.J., Yang, C.K. and Ling, K.H. (1975) [Physico-chemical characteristics of drinking water in blackfoot endemic areas in Chia-I and Tainan Hsiens]. Taiwan Yi Xue Hui Za Zhi, 74, 596-605.
Macaluso, M., Russo, G., Cinti, C., Bazan, V., Gebbia, N. and Russo, A. (2002) Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol, 192, 125-130.
Marais, R. and Marshall, C.J. (1996) Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv, 27, 101-125.
Marais, R., Wynne, J. and Treisman, R. (1993) The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell, 73, 381-393.
Marino, G., Uria, J.A., Puente, X.S., Quesada, V., Bordallo, J. and Lopez-Otin, C. (2003) Human autophagins, a family of cysteine proteinases potentially implicated in cell degradation by autophagy. J Biol Chem, 278, 3671-3678.
Mason, C.S., Springer, C.J., Cooper, R.G., Superti-Furga, G., Marshall, C.J. and Marais, R. (1999) Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J, 18, 2137-2148.
Mattson, M.P. (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol, 1, 120-129.
McCawley, L.J., Li, S., Wattenberg, E.V. and Hudson, L.G. (1999) Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J Biol Chem, 274, 4347-4353.
McPherson, R.A., Harding, A., Roy, S., Lane, A. and Hancock, J.F. (1999) Interactions of c-Raf-1 with phosphatidylserine and 14-3-3. Oncogene, 18, 3862-3869.
Mitsuuchi, Y., Johnson, S.W., Selvakumaran, M., Williams, S.J., Hamilton, T.C. and Testa, J.R. (2000) The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Cancer Res, 60, 5390-5394.
Miyoshi, Y., Iwao, K., Egawa, C. and Noguchi, S. (2001) Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. International Journal of Cancer, 92, 370-373.
Moertel, C.G., Fleming, T.R., Macdonald, J.S., Haller, D.G., Laurie, J.A., Goodman, P.J., Ungerleider, J.S., Emerson, W.A., Tormey, D.C., Glick, J.H. and et al. (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med, 322, 352-358.
Monia, B.P., Johnston, J.F., Ecker, D.J., Zounes, M.A., Lima, W.F. and Freier, S.M. (1992) Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J Biol Chem, 267, 19954-19962.
Monia, B.P., Lesnik, E.A., Gonzalez, C., Lima, W.F., McGee, D., Guinosso, C.J., Kawasaki, A.M., Cook, P.D. and Freier, S.M. (1993) Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem, 268, 14514-14522.
Moreno-Bueno, G., Sanchez-Estevez, C., Cassia, R., Rodriguez-Perales, S., Diaz-Uriarte, R., Dominguez, O., Hardisson, D., Andujar, M., Prat, J., Matias-Guiu, X., Cigudosa, J.C. and Palacios, J. (2003) Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res, 63, 5697-5702.
Morrison, D.K. (1995) Mechanisms regulating Raf-1 activity in signal transduction pathways. Mol Reprod Dev, 42, 507-514.
Murnion, M.E., Adams, R.R., Callister, D.M., Allis, C.D., Earnshaw, W.C. and Swedlow, J.R. (2001) Chromatin-associated protein phosphatase 1 regulates aurora-B and histone H3 phosphorylation. Journal of Biological Chemistry, 276, 26656-26665.
Nancy, V., Wolthuis, R.M., de Tand, M.F., Janoueix-Lerosey, I., Bos, J.L. and de Gunzburg, J. (1999) Identification and characterization of potential effector molecules of the Ras-related GTPase Rap2. Journal of Biological Chemistry, 274, 8737-8745.
Neben, K., Korshunov, A., Benner, A., Wrobel, G., Hahn, M., Kokocinski, F., Golanov, A., Joos, S. and Lichter, P. (2004) Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res, 64, 3103-3111.
Nguyen, A., Burack, W.R., Stock, J.L., Kortum, R., Chaika, O.V., Afkarian, M., Muller, W.J., Murphy, K.M., Morrison, D.K., Lewis, R.E., McNeish, J. and Shaw, A.S. (2002) Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol Cell Biol, 22, 3035-3045.
Nielsen, L.L., Gurnani, M. and Tyler, R.D. (1992) Evaluation of the wap-ras transgenic mouse as a model system for testing anticancer drugs. Cancer Res, 52, 3733-3738.
Nigg, E. (2001) Mitotic kinases as regulators of cell division and its checkpoints. Nature Review Molecular Cell Biology, 2, 21-32.
Nimnual, A.S., Yatsula, B.A. and Bar-Sagi, D. (1998) Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science, 279, 560-563.
Ogier-Denis, E. and Codogno, P. (2003) Autophagy: a barrier or an adaptive response to cancer. Biochim Biophys Acta, 1603, 113-128.
Ohtani, T., Hatori, M., Ito, H., Takizawa, K., Kamijo, R. and Nagumo, M. (2000) Involvement of caspases in 5-FU induced apoptosis in an oral cancer cell line. Anticancer Res, 20, 3117-3121.
Okazaki, M., Kishida, S., Hinoi, T., Hasegawa, T., Tamada, M., Kataoka, T. and Kikuchi, A. (1997) Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator. Oncogene, 14, 515-521.
Ory, S. and Morrison, D.K. (2004) Signal transduction: implications for Ras-dependent ERK signaling. Curr Biol, 14, R277-278.
Ory, S., Zhou, M., Conrads, T.P., Veenstra, T.D. and Morrison, D.K. (2003) Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr Biol, 13, 1356-1364.
Park, S.H. and Weinberg, R.A. (1995) A putative effector of Ral has homology to Rho/Rac GTPase activating proteins. Oncogene, 11, 2349-2355.
Pells, S., Divjak, M., Romanowski, P., Impey, H., Hawkins, N.J., Clarke, A.R., Hooper, M.L. and Williamson, D.J. (1997) Developmentally-regulated expression of murine K-ras isoforms. Oncogene, 15, 1781-1786.
Peters, G., Wets, M., Keepers, YP., Oskam, R., van Ark-Otte, J., Noordhuis, P., Smid, K., and Pinedo, HM. (1993) Transformation of mouse fibroblasts with the oncogene H-ras or trk is associated with pronounced changes in drug sensitivity and metabolism. Int. J. Cancer, 54, 450-455.
Price, M.A., Cruzalegui, F.H. and Treisman, R. (1996) The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c-fos transcription in response to UV light. EMBO Journal, 15, 6552-6563.
Quilliam, L.A., Rebhun, J.F. and Castro, A.F. (2002) A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases. Prog Nucleic Acid Res Mol Biol, 71, 391-444.
Raabe, T. and Rapp, U.R. (2002) KSR--a regulator and scaffold protein of the MAPK pathway. Sci STKE, 2002, PE28.
Rabin, M., Watson, M., Barker, P.E., Ryan, J., Breg, W.R. and Ruddle, F.H. (1984) NRAS transforming gene maps to region p11----p13 on chromosome 1 by in situ hybridization. Cytogenet Cell Genet, 38, 70-72.
Rao, V.N. and Reddy, E.S. (1992) elk-1 domains responsible for autonomous DNA binding, SRE:SRF interaction and negative regulation of DNA binding. Oncogene, 7, 2335-2340.
Rao, V.N. and Reddy, E.S. (1994) elk-1 proteins interact with MAP kinases. Oncogene, 9, 1855-1860.
Razidlo, G.L., Kortum, R.L., Haferbier, J.L. and Lewis, R.E. (2004) Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation. J Biol Chem, 279, 47808-47814.
Reichardt, W., Jung, V., Brunner, C., Klein, A., Wemmert, S., Romeike, B.F., Zang, K.D. and Urbschat, S. (2003) The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas. Oncol Rep, 10, 1275-1279.
Reuther, G.W. and Der, C.J. (2000) The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr Opin Cell Biol, 12, 157-165.
Riddle, D.L. and Gorski, S.M. (2003) Shaping and stretching life by autophagy. Dev Cell, 5, 364-365.
Rodriguez-Viciana, P., Warne, P.H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M.J., Waterfield, M.D. and Downward, J. (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature, 370, 527-532.
Rodriguez-Viciana, P., Warne, P.H., Vanhaesebroeck, B., Waterfield, M.D. and Downward, J. (1996) Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J, 15, 2442-2451.
Rommel, C., Clarke, BA., Zimmermann, S., Nunez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, GD., and Glaa, DJ. (1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Sciece, 286, 1738-1741.
Roy, F., Laberge, G., Douziech, M., Ferland-McCollough, D. and Therrien, M. (2002) KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev, 16, 427-438.
Roy, F. and Therrien, M. (2002) MAP kinase module: the Ksr connection. Curr Biol, 12, R325-327.
Russo, P., Malacarne, D., Falugi, C., Trombino, S. and O'Connor, P.M. (2002) RPR-115135, a farnesyltransferase inhibitor, increases 5-FU- cytotoxicity in ten human colon cancer cell lines: role of p53. Int J Cancer, 100, 266-275.
Saavedra, H.I., Fukasawa, K., Conn, C.W. and Stambrook, P.J. (1999) MAPK mediates RAS-induced chromosome instability. J Biol Chem, 274, 38083-38090.
Saavedra, H.I., Knauf, J.A., Shirokawa, J.M., Wang, J., Ouyang, B., Elisei, R., Stambrook, P.J. and Fagin, J.A. (2000) The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway. Oncogene, 19, 3948-3954.
Sachdev, P., Zeng, L. and Wang, L.H. (2002) Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes. J Biol Chem, 277, 17638-17648.
Sahai, E., Olson, M.F. and Marshall, C.J. (2001) Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. Embo J, 20, 755-766.
Sakaguchi, A.Y., Zabel, B.U., Grzeschik, K.H., Law, M.L., Ellis, R.W., Scolnick, E.M. and Naylor, S.L. (1984) Regional localization of two human cellular Kirsten ras genes on chromosomes 6 and 12. Mol Cell Biol, 4, 989-993.
Sakakura, C., Hagiwara, A., Yasuoka, R., Fujita, Y., Nakanishi, M., Masuda, K., Shimomura, K., Nakamura, Y., Inazawa, J., Abe, T. and Yamagishi, H. (2001) Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. British Journal of Cancer, 84, 824-831.
Schaeffer, H.J., Catling, A.D., Eblen, S.T., Collier, L.S., Krauss, A. and Weber, M.J. (1998) MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science, 281, 1668-1671.
Schwartz, D.C. and Hochstrasser, M. (2003) A superfamily of protein tags: ubiquitin, SUMO and related modifiers. Trends Biochem Sci, 28, 321-328.
Schwieger, A., Bauer, L., Hanusch, J., Sers, C., Schafer, R. and Bauer, G. (2001) ras oncogene expression determines sensitivity for intercellular induction of apoptosis. Carcinogenesis, 22, 1385-1392.
Scrittori, L., Hans, F., Angelov, D., Charra, M., Prigent, C. and Dimitrov, S. (2001) pEg2 aurora-A kinase, histone H3 phosphorylation, and chromosome assembly in Xenopus egg extract. Journal of Biological Chemistry, 276, 30002-30010.
Sebolt-Leopold, J.S. (2000) Development of anticancer drugs targeting the MAP kinase pathway. Oncogene, 19, 6594-6599.
Sebolt-Leopold, J.S., Dudley, D.T., Herrera, R., Van Becelaere, K., Wiland, A., Gowan, R.C., Tecle, H., Barrett, S.D., Bridges, A., Przybranowski, S., Leopold, W.R. and Saltiel, A.R. (1999) Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med, 5, 810-816.
Sen, S., Zhou, H., Zhang, R.D., Yoon, D.S., Vakar-Lopez, F., Ito, S., Jiang, F., Johnston, D., Grossman, H.B., Ruifrok, A.C., Katz, R.L., Brinkley, W. and Czerniak, B. (2002) Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst, 94, 1320-1329.
Senger, D.R., Perruzzi, C.A. and Ali, I.U. (1988) T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen. Proc Natl Acad Sci U S A, 85, 5107-5111.
Shields, J.M., Pruitt, K., McFall, A., Shaub, A. and Der, C.J. (2000) Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol, 10, 147-154.
Shore, P. and Sharrocks, A.D. (1994) The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1. Molecular & Cellular Biology, 14, 3283-3291.
Silvius, J.R. (2002) Mechanisms of Ras protein targeting in mammalian cells. J Membr Biol, 190, 83-92.
Simon, C., Hicks, M.J., Nemechek, A.J., Mehta, R., O'Malley, B.W., Jr., Goepfert, H., Flaitz, C.M. and Boyd, D. (1999) PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma. Br J Cancer, 80, 1412-1419.
Slee, E.A., Harte, M.T., Kluck, R.M., Wolf, B.B., Casiano, C.A., Newmeyer, D.D., Wang, H.G., Reed, J.C., Nicholson, D.W., Alnemri, E.S., Green, D.R. and Martin, S.J. (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol, 144, 281-292.
Spaargaren, M. and Bischoff, J.R. (1994) Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. Proc Natl Acad Sci U S A, 91, 12609-12613.
Spandidos, D.A., Sourvinos, G., Tsatsanis, C. and Zafiropoulos, A. (2002) Normal ras genes: their onco-suppressor and pro-apoptotic functions (review). Int J Oncol, 21, 237-241.
Srinivasula, S.M., Ahmad, M., Fernandes-Alnemri, T. and Alnemri, E.S. (1998) Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell, 1, 949-957.
Stennicke, H.R. and Salvesen, G.S. (1997) Biochemical characteristics of caspases-3, -6, -7, and -8. J Biol Chem, 272, 25719-25723.
Suzuki, K., Kazui, T., Yoshida, M., Uno, T., Kobayashi, T., Kimura, T., Yoshida, T. and Sugimura, H. (1999) Drug-induced apoptosis and p53, BCL-2 and BAX expression in breast cancer tissues in vivo and in fibroblast cells in vitro. Jpn J Clin Oncol, 29, 323-331.
Taal, B.G., Van Tinteren, H. and Zoetmulder, F.A. (2001) Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer, 85, 1437-1443.
Tanaka, T., Kimura, M., Matsunaga, K., Fukada, D., Mori, H. and Okano, Y. (1999) Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. Cancer Res, 59, 2041-2044.
Tang, D.G. and Porter, A.T. (1996) Apoptosis: A Current Molecular Analysis. Pathol Oncol Res, 2, 117-131.
Tanner, M.M., Tirkkonen, M., Kallioniemi, A., Collins, C., Stokke, T., Karhu, R., Kowbel, D., Shadravan, F., Hintz, M., Kuo, W.L. and et al. (1994) Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res, 54, 4257-4260.
Tanner, M.M., Tirkkonen, M., Kallioniemi, A., Holli, K., Collins, C., Kowbel, D., Gray, J.W., Kallioniemi, O.P. and Isola, J. (1995) Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res, 1, 1455-1461.
Tatsuka, M., Sato, S., Kitajima, S., Suto, S., Kawai, H., Miyauchi, M., Ogawa, I., Maeda, M., Ota, T. and Takata, T. (2004) Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis. Oncogene, 24, 1122-1127.
Tatsuka, M., Sato, S., Kitajima, S., Suto, S., Kawai, H., Miyauchi, M., Ogawa, I., Maeda, M., Ota, T. and Takata, T. (2005) Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis. Oncogene, 24, 1122-1127.
Tong, W. and Pollard, J.W. (2001) Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice. Mol Cell Biol, 21, 1319-1328.
Trieselmann, N., Armstrong, S., Rauw, J. and Wilde, A. (2003) Ran modulates spindle assembly by regulating a subset of TPX2 and Kid activities including Aurora A activation. J Cell Sci, 116, 4791-4798.
Tsai, M.Y., Wiese, C., Cao, K., Martin, O., Donovan, P., Ruderman, J., Prigent, C. and Zheng, Y. (2003) A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly. Nat Cell Biol, 5, 242-248.
Tsai, S.M., Wang, T.N. and Ko, Y.C. (1998) Cancer mortality trends in a blackfoot disease endemic community of Taiwan following water source replacement. J Toxicol Environ Health A, 55, 389-404.
Tseng, W.P. (1970) Prognosis of blackfoot disease. A 10-year follow-up study. Taiwan Yi Xue Hui Za Zhi, 69, 1-21.
Tseng, W.P. (1977) Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect, 19, 109-119.
Tseng, Y.S., Tzeng, C.C., Chiu, A.W., Lin, C.H., Won, S.J., Wu, I.C. and Liu, H.S. (2003) Ha-ras overexpression mediated cell apoptosis in the presence of 5-fluorouracil. Exp Cell Res, 288, 403-414.
Tzeng, C.C., Liu, H.S., Li, C., Jin, Y.T., Chen, R.M., Yang, W.H. and Lin, J.S. (1996) Characterization of two urothelium cancer cell lines derived from a blackfoot disease endemic area in Taiwan. Anticancer Res., 16, 1797-1804.
Ueda, M., Kumagai, K., Ueki, K., Inoki, C., Orino, I. and Ueki, M. (1997) Groowth inhibtion and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluoroucil. Int. J. Cancer, 71, 668-674.
Umanoff, H., Edelmann, W., Pellicer, A. and Kucherlapati, R. (1995) The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci U S A, 92, 1709-1713.
Verheij, M., Bose, R., Lin, X.H., Yao, B., Jarvis, W.D., Grant, S.K., Birrer, K.M.J., Szabo, E., Zon, L.I., Kyriakis, J.M., Haimovitz-Friedman, A., Fuks, Z. and Kolesnick, R.N. (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature, 380, 75-79.
Walker, K. and Olson, M.F. (2005) Targeting Ras and Rho GTPases as opportunities for cancer therapeutics. Curr Opin Genet Dev, 15, 62-68.
Wang, C.W. and Klionsky, D.J. (2003) The molecular mechanism of autophagy. Mol Med, 9, 65-76.
Wang, H.G., Rapp, U.R. and Reed, J.C. (1996) Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell, 87, 629-638.
Webb, C.P., Van Aelst, L., Wigler, M.H. and Woude, G.F. (1998) Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci U S A, 95, 8773-8778.
White, M.A., Vale, T., Camonis, J.H., Schaefer, E. and Wigler, M.H. (1996) A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J Biol Chem, 271, 16439-16442.
Whitmarsh, A.J., Shore, P., Sharrocks, A.D. and Davis, R.J. (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science, 269, 403-407.
Widmann, C., Gibson, S., Jarpe, M.B. and Johnson, G.L. (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev, 79, 143-180.
Wilsbacher, J.L., Goldsmith, E.J. and Cobb, M.H. (1999) Phosphorylation of MAP kinases by MAP/ERK involves multiple regions of MAP kinases. J Biol Chem, 274, 16988-16994.
Wittmann, T., Wilm, M., Karsenti, E. and Vernos, I. (2000) TPX2, A novel xenopus MAP involved in spindle pole organization. J Cell Biol, 149, 1405-1418.
Wolthuis, R.M. and Bos, J.L. (1999) Ras caught in another affair: the exchange factors for Ral. Curr Opin Genet Dev, 9, 112-117.
Wong, W.W., Dimitroulakos, J., Minden, M.D. and Penn, L.Z. (2002) HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia, 16, 508-519.
Wu, J.C., Chen, T.Y., Yu, C.T., Tsai, S.J., Hsu, J.M., Tang, M.J., Chou, C.K., Lin, W.J., Yuan, C.J. and Huang, C.Y. (2005) Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening. J Biol Chem, 280, 9013-9022.
Wu, M.M., Kuo, T.L., Hwang, Y.H. and Chen, C.J. (1989) Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol, 130, 1123-1132.
Wymann, M.P. and Pirola, L. (1998) Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta, 1436, 127-150.
Yan, J., Roy, S., Apolloni, A., Lane, A. and Hancock, J.F. (1998) Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem, 273, 24052-24056.
Yang, C.Y., Chiu, H.F., Chang, C.C., Ho, S.C. and Wu, T.N. (2005) Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan. Environ Res, 98, 127-132.
Yordy, J.S. and Muise-Helmericks, R.C. (2000) Signal transduction and the Ets family of transcription factors. Oncogene, 19, 6503-6513.
Yu, W., Fantl, W.J., Harrowe, G. and Williams, L.T. (1998) Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK. Curr Biol, 8, 56-64.
Zhang, J., Reedy, MC., Hannun, YA., and Obeid, LM. (1999) Inhibition of caspases inhibits the release of apoptotic bodies: Bcl-2 inhibits initiation of apoptotic bodies in chemotherapeutic agent-induced apoptosis. J. Cell Biol., 145, 99-108.
Zheng, M., Wang, H., Zhang, H., Ou, Q., Shen, B., Li, N. and Yu, B. (1999) The influence of the p53 gene on the in vitro chemosensitivity of colorectal cancer cells. J Cancer Res Clin Oncol, 125, 357-360.
Zhou, H., Kuang, J., Zhong, L., Kuo, W.L., Gray, J.W., Sahin, A., Brinkley, B.R. and Sen, S. (1998) Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genetics, 20, 189-193.
Zhu, K., Gerbino, E., Beaupre, D.M., Mackley, P.A., Muro-Cacho, C., Beam, C., Hamilton, A.D., Lichtenheld, M.G., Kerr, W.G., Dalton, W., Alsina, M. and Sebti, S.M. (2005) Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells. Blood, 105, 4759-4766.
Zimmermann, K.C., Bonzon, C. and Green, D.R. (2001) The machinery of programmed cell death. Pharmacol Ther, 92, 57-70.
Zimmermann, K.C. and Green, D.R. (2001) How cells die: apoptosis pathways. J Allergy Clin Immunol, 108, S99-103.
Zimmermann, S., and Moelling, K. (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science, 286, 1741-1744.
Zwartkruis, F.J., Wolthuis, R.M., Nabben, N.M., Franke, B. and Bos, J.L. (1998) Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO Journal, 17, 5905-5912.
|